Ethical Profile
Mixed.
Not enough information to create an ethical profile.
FBLG.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
FibroBiologics, Inc. is a biotechnology company focused on the development of fibroblast-based therapies for chronic diseases. The company engineers human fibroblasts to secrete therapeutic proteins, aiming to address unmet needs in areas such as wound healing, cancer, and degenerative diseases. The...Show More
Ethical Profile
Not enough information to create an ethical profile.
Similar Companies
No evidence available to assess FibroBiologics, Inc. on Better Health for All.
No evidence available to assess FibroBiologics, Inc. on Fair Money & Economic Opportunity.
No relevant data was found in the provided article to assess FBLG.US against the Fair Pay & Worker Respect ethical value.
No evidence available to assess FibroBiologics, Inc. on Fair Trade & Ethical Sourcing.
The company's board of directors has six independent members out of a total of seven, meaning approximately 85.7% are conflict-free.
FibroBiologics conducts extensive preclinical animal studies for its product candidates, including using diabetic mice, rabbit models, psoriasis mouse models, EAE animal models, and xenografted melanoma mouse models.
The company is a clinical-stage biotechnology firm focused on fibroblast-based therapies and is explicitly stated as not being a defense contractor, indicating no defense or arms-related activities in its core business.
No evidence was found in the provided articles to assess FibroBiologics, Inc. against any of the Planet-Friendly Business KPIs. The articles focus on general biopharmaceutical industry news, research and development of therapies, and a counterproposal to research overhead cuts, none of which contain specific data points related to environmental performance, targets, or initiatives for FBLG.US.
No evidence available to assess FibroBiologics, Inc. on Respect for Cultures & Communities.
The company states that no personal information is shared, indicating strong preventative measures against unauthorized data use.
No specific, concrete data points were found for FBLG.US regarding any of the 'Zero Waste & Sustainable Products' KPIs. The articles provided general information about sustainability in the biotech industry, examples from other companies, or focused on FBLG.US's financial and clinical trial updates, but did not offer measurable evidence for FBLG.US's waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.